Literature DB >> 21876875

Prenatally programmed hypertension: role of maternal diabetes.

G N Gomes1, F Z Gil.   

Abstract

Epidemiological and experimental studies have led to the hypothesis of the fetal origin of adult diseases, suggesting that some adult diseases might be determined before birth by altered fetal development. Maternal diabetes subjects the fetus to an adverse environment that has been demonstrated to result in metabolic, cardiovascular and renal impairment in the offspring. The growing amount of obesity in young females in developed and some developing countries should contribute to increasing the incidence of diabetes among pregnant women. In this review, we discuss how renal and extrarenal mechanisms participate in the genesis of hypertension induced by a diabetic status during fetal development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21876875     DOI: 10.1590/s0100-879x2011007500109

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  3 in total

1.  Sex-specific programming of hypertension in offspring of late-gestation diabetic rats.

Authors:  Ragheed Katkhuda; Emily S Peterson; Robert D Roghair; Andrew W Norris; Thomas D Scholz; Jeffrey L Segar
Journal:  Pediatr Res       Date:  2012-07-17       Impact factor: 3.756

2.  Long Lasting Microvascular Tone Alteration in Rat Offspring Exposed In Utero to Maternal Hyperglycaemia.

Authors:  Emilie Vessières; Abdallah Dib; Jennifer Bourreau; Eric Lelièvre; Marc-Antoine Custaud; Martine Lelièvre-Pégorier; Laurent Loufrani; Daniel Henrion; Céline Fassot
Journal:  PLoS One       Date:  2016-01-12       Impact factor: 3.240

3.  In Utero Exposure to Maternal Diabetes Is Associated With Early Abnormal Vascular Structure in Offspring.

Authors:  Abdallah Dib; Cyrielle Payen; Jennifer Bourreau; Mathilde Munier; Linda Grimaud; Ziad Fajloun; Laurent Loufrani; Daniel Henrion; Céline Fassot
Journal:  Front Physiol       Date:  2018-04-04       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.